📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-05 17:50
0 analysed today
FollowTelegram
0
Today
151,859
All-time analysed
43,535
Positive
6,743
Negative
92,744
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
4 announcements match the current filters (relevance ≥ 5).
Resignation of Chairman Venkata Sandeep Kumar Reddy Effective August 5, 2026
Mr. Venkata Sandeep Kumar Reddy Tikkavarapu has resigned as Chairman and Non-Executive Director of Gayatri BioOrganics Ltd, effective August 5, 2026. The resignation occurs while the company is in severe financial distress, reporting zero revenue for the last four quarters and a negative net worth of ₹37 Cr. The outgoing Chairman cited professional responsibilities and personal reasons for his departure. This leadership exit follows a significant 62.5% decline in the company's share price over the past three months.
Confidence: HIGH
What changedThe Chairman and Non-Executive Director has stepped down from the Board and all associated committees.
Why it mattersThe exit of top leadership in a company with negative net worth and stalled operations increases uncertainty regarding its ability to service its ₹38 Cr debt or pivot to a viable business model.
Effective Date: 05.08.2026TTM Revenue: ₹0 CrNet Worth: ₹-37 CrDebt: ₹38 Cr3-Month Price Return: -62.5%
📅 Short termThe resignation is likely to weigh further on investor sentiment, which is already weak due to the lack of operational revenue.
📈 Long termThe company's long-term survival depends on a complete restructuring of its negative net worth and finding a new revenue stream; leadership instability complicates this.
⚠ Risk flags
- Negative net worth of ₹37 Cr
- Zero operational revenue
- High debt relative to market cap
- Significant share price erosion
Key Highlights
Resignation of the Chairman is effective from August 5, 2026
Company reported ₹0.0 Cr revenue for the trailing twelve months (TTM)
Net worth is currently negative at ₹-37 Cr with a debt of ₹38 Cr
Share price has seen a sharp decline of 62.5% over the last 3 months
👀 What to Watch
Investors should monitor for the appointment of a successor and any management commentary regarding the resumption of business operations, given the current zero-revenue status.
Gayatri BioOrganics reports Rs 2.34 Cr revenue in Q1; proposes name change and leadership shift
Gayatri BioOrganics reported a revenue of Rs 2.34 Cr for the quarter ended June 30, 2026, marking a significant shift from zero revenue in the preceding four quarters. The company is undergoing a major transition, proposing a name change to 'Ananth BioOrganics Limited' and announcing the resignation of its Chairman, Mr. Venkata Sandeep Kumar Reddy. Mr. Sreedhara Reddy Kanaparthi has been elevated to Chairman and Managing Director for a three-year term. Despite the revenue resumption, the company remains loss-making with a net loss of Rs 0.10 Cr and a deeply negative net worth of Rs 37 Cr.
Confidence: HIGH
What changedThe company has resumed operations (generating revenue after a long hiatus), changed its top leadership, and initiated a rebranding process to 'Ananth BioOrganics'.
Why it mattersThis represents a potential turnaround attempt for a technically insolvent company (negative net worth) that has been non-operational for several quarters.
Revenue (Q1 FY27): Rs 2.34 CrNet Loss (Q1 FY27): Rs 0.10 CrNet Worth: Rs -37.00 CrResigning Director Shareholding: 1,70,06,802 unitsDebt: Rs 38 Cr
📅 Short termThe resumption of revenue is a positive sign, but the resignation of the Chairman and the negative net worth will likely keep the stock volatile in the near term.
📈 Long termThe long-term viability depends entirely on the new management's ability to scale operations and resolve the massive debt and negative equity position.
⚠ Risk flags
- Negative net worth of Rs 37 Cr
- Going concern uncertainty
- High debt relative to market cap
- Management transition during financial distress
Key Highlights
Revenue from operations stood at Rs 2.34 Cr in Q1 FY27, compared to zero revenue in the previous four quarters.
Net loss narrowed to Rs 0.10 Cr for the quarter ended June 30, 2026, from a loss of Rs 0.26 Cr in the same period last year.
Chairman Mr. Venkata Sandeep Kumar Reddy resigned effective August 5, 2026, citing personal reasons.
Mr. Sreedhara Reddy Kanaparthi appointed as Chairman and Managing Director for a 3-year term starting August 5, 2026.
Company net worth remains negative at Rs -37.00 Cr, with financials prepared on a 'going concern' basis supported by promoter comfort letters.
👀 What to Watch
Investors should monitor the sustainability of the newly generated revenue and check for any capital infusion or debt restructuring plans in the upcoming AGM on September 23, 2026.
Gayatri BioOrganics reports Rs 2.34 Cr revenue in Q1; proposes name change and leadership shift
Gayatri BioOrganics reported a revenue of Rs 2.34 Cr for the quarter ended June 30, 2026, a significant shift from zero revenue in the previous four quarters. The company narrowed its net loss to Rs 0.10 Cr from a loss of Rs 0.42 Cr in the preceding quarter. Major corporate changes include a proposed name change to "Ananth BioOrganics" and the resignation of Chairman Venkata Sandeep Kumar Reddy. Mr. Sreedhara Reddy Kanaparthi has been elevated to Chairman and Managing Director for a three-year term.
Confidence: HIGH
What changedThe company has resumed operations with Rs 2.34 Cr in revenue after a long period of inactivity and is undergoing a complete rebranding and leadership overhaul.
Why it mattersThis marks a potential pivot from a dormant entity to an active business; however, the negative net worth of Rs 37 Cr and high debt levels remain critical solvency concerns.
Revenue (Q1 FY27): Rs 2.34 CrNet Loss (Q1 FY27): Rs 0.10 CrNet Worth: Rs -37.00 CrDebt: Rs 38 CrAGM Date: 23rd September 2026
📅 Short termThe resumption of revenue is a positive signal, but the market will likely remain cautious due to the Chairman's exit and the severely stressed balance sheet.
📈 Long termThe company's survival depends on scaling the new business model to a level that can service its Rs 38 Cr debt and eventually restore its eroded net worth.
⚠ Risk flags
- Negative net worth (Rs -37 Cr)
- High debt (Rs 38 Cr)
- Management instability with the resignation of the Chairman
- Going concern status depends on promoter support
Key Highlights
Revenue from operations reached Rs 2.34 Cr in Q1 FY27, compared to zero revenue in the entire FY26.
Net loss narrowed to Rs 10.17 Lakhs from a loss of Rs 42.05 Lakhs in the March 2026 quarter.
Chairman Venkata Sandeep Kumar Reddy resigned effective August 5, 2026, citing personal reasons.
Company net worth remains deeply negative at Rs -37.00 Cr as of June 30, 2026.
Total expenses for the quarter were Rs 2.44 Cr, primarily driven by purchase of stock-in-trade worth Rs 2.15 Cr.
👀 What to Watch
Monitor the sustainability of the new revenue stream in upcoming quarters and the outcome of the AGM on September 23, 2026, regarding the rebranding and management transition.
Gayatri BioOrganics Reports ₹2.33 Cr Revenue in Q1 FY27; Proposes Name Change and New CMD
Gayatri BioOrganics has resumed revenue generation, reporting ₹233.66 Lakhs in Q1 FY27 after four consecutive quarters of zero revenue. The company narrowed its net loss to ₹10.17 Lakhs from ₹26.29 Lakhs in the same period last year. A significant leadership transition occurred with the resignation of Chairman Mr. Venkata Sandeep Kumar Reddy Tikkavarapu and the appointment of Mr. Sreedhara Reddy Kanaparthi as the new Chairman and Managing Director. The board also approved a name change to 'Ananth BioOrganics Limited' (or similar variants), signaling a potential brand pivot.
Confidence: HIGH
What changedThe company has resumed operations/trading after a year of zero revenue and has appointed a new Chairman and Managing Director while proposing a complete change in corporate identity.
Why it mattersThe resumption of revenue is a critical first step for a company with negative net worth and high debt, though the reliance on 'Stock-in-trade' suggests low-margin activity. The management overhaul and name change indicate a fresh attempt at restructuring the business.
Revenue from Operations (Q1 FY27): ₹233.66 LakhsNet Loss (Q1 FY27): ₹10.17 LakhsNet Worth: ₹(3,700.49) LakhsPurchase of Stock-In-Trade: ₹215.45 LakhsDebt to Market Cap Ratio: ~69%
📅 Short termThe market may react to the resumption of revenue and management changes, but the fundamental financial health remains weak due to negative equity.
📈 Long termStructural recovery is uncertain; the company remains a 'going concern' only due to promoter support letters. Long-term viability depends on moving beyond trading into sustainable manufacturing operations.
⚠ Risk flags
- Negative net worth of ₹37 Cr
- Going concern uncertainty noted by auditors
- High debt of ₹38 Cr relative to ₹55 Cr market cap
- Thin margins on trading-led revenue
Key Highlights
Revenue from operations reached ₹233.66 Lakhs in Q1 FY27, compared to zero revenue in the previous four quarters.
Net loss narrowed to ₹10.17 Lakhs for the quarter ended June 30, 2026.
Total expenses of ₹243.84 Lakhs were primarily driven by 'Purchase of Stock-In-Trade' amounting to ₹215.45 Lakhs.
Net worth remains deeply negative at ₹(3,700.49) Lakhs as of June 30, 2026.
Resignation of Chairman Mr. Venkata Sandeep Kumar Reddy Tikkavarapu effective August 5, 2026.
👀 What to Watch
Investors should monitor if the newly resumed revenue (which appears to be trading-led) can scale and generate sufficient margins to address the company's negative net worth of ₹37 Cr. Watch for the upcoming AGM on September 23, 2026, for further clarity on the business pivot and name change.
